Cite Filings / ALGS / 0001193125-21-134253

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Aligos Therapeutics, Inc. Filed 2021-04-27 Acc 0001193125-21-134253

Documents 1

DEF 14A Proxy Statement , d65632ddef14a.htm

Around this filing

2022-04-29 DEF 14A Proxy Statement
2021-04-28 4 Director disposed of 504,084 shares (other)
2021-04-27 4 Options or other derivatives
2021-04-27 3 Initial Statement of Ownership
2021-04-27 DEFA14A Proxy Materials
2021-04-27 DEF 14A Proxy Statement
2021-04-27 8-K Executive or director change

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d65632ddef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…